O'Reilly, Richard J.

Publications

Sort by

Co-Author Network

selected publications

⁸⁹Zr-immunoPET-guided selection of a CD33xIL15 fusion protein optimized for antitumor immune cell activation and in vivo tumour retention in acute myeloid leukaemia. European journal of nuclear medicine and molecular imaging. 2024 Academic Article GET IT
Profile of a Pioneer: Robert A. Good. Transplantation and cellular therapy. 2024 Academic Article GET IT
Persistent or new cytopenias predict relapse better than routine bone marrow aspirate evaluations after hematopoietic cell transplantation for acute leukemia or myelodysplastic syndrome in children and young adult patients. Transplantation and cellular therapy. 2024 Academic Article GET IT
Management of a major varicella zoster exposure in a pediatric oncology population. Pediatric hematology and oncology. 2024 Academic Article GET IT
Relevance of lymphocyte proliferation to PHA in severe combined immunodeficiency (SCID) and T cell lymphopenia. Clinical immunology (Orlando, Fla.). 2024 Academic Article GET IT
Impact of rabbit anti-thymocyte globulin (ATG) exposure on outcomes after ex vivo T-cell-depleted hematopoietic cell transplantation in pediatric and young adult patients. Cytotherapy. 2024 Academic Article GET IT
Tabelecleucel for allogeneic haematopoietic stem-cell or solid organ transplant recipients with Epstein-Barr virus-positive post-transplant lymphoproliferative disease after failure of rituximab or rituximab and chemotherapy (ALLELE): a phase 3, multicentre, open-label trial. The Lancet. Oncology. 2024 Academic Article GET IT
Post-Transplant Late Complications Increase Over Time for Patients with SCID: A Primary Immune Deficiency Treatment Consortium (PIDTC) Landmark Study. The Journal of allergy and clinical immunology. 2023 Academic Article GET IT
T-cell depleted allogeneic hematopoietic stem cell transplant for the treatment of Fanconi anemia and MDS/AML. Bone marrow transplantation. 2023 Academic Article GET IT
Association between busulfan exposure and survival in patients undergoing a CD34+ selected stem cell transplantation. Blood advances. 2023 Academic Article GET IT
The landscape of MHC-presented phosphopeptides yields actionable shared tumor antigens for cancer immunotherapy across multiple HLA alleles. Journal for immunotherapy of cancer. 2023 Academic Article GET IT
Emapalumab as bridge to hematopoietic cell transplant for STAT1 gain-of-function mutations. The Journal of allergy and clinical immunology. 2023 Letter GET IT
Measuring the effect of newborn screening on survival after haematopoietic cell transplantation for severe combined immunodeficiency: a 36-year longitudinal study from the Primary Immune Deficiency Treatment Consortium. Lancet (London, England). 2023 Academic Article GET IT
Times cited: 27
Cytomegalovirus-specific T cells following haploidentical transplants: reshaping a repertoire by half. Haematologica. 2023 Editorial Article GET IT
Third-party cytomegalovirus-specific T cells improved survival in refractory cytomegalovirus viremia after hematopoietic transplant. The Journal of clinical investigation. 2023 Academic Article GET IT
Times cited: 22
T-cells: Third Party Parity for Viral Infections. Transplantation and cellular therapy. 2023 Academic Article GET IT
The landscape of MHC-presented phosphopeptides yields actionable shared tumor antigens for cancer immunotherapy across multiple HLA alleles. 2023 GET IT
Times cited: 16
The diagnosis of severe combined immunodeficiency (SCID): The Primary Immune Deficiency Treatment Consortium (PIDTC) 2022 Definitions. The Journal of allergy and clinical immunology. 2022 Academic Article GET IT
Times cited: 38
The diagnosis of severe combined immunodeficiency: Implementation of the PIDTC 2022 Definitions. The Journal of allergy and clinical immunology. 2022 Academic Article GET IT
Times cited: 18
Durable Engraftment and Excellent Overall Survival After CD34-Selected Peripheral Blood Stem Cell Boost in Pediatric Patients With Poor Graft Function Following Allogeneic Stem Cell Transplantation. Transplantation and cellular therapy. 2022 Academic Article GET IT
Times cited: 6
Outcomes following treatment for ADA-deficient severe combined immunodeficiency: a report from the PIDTC. Blood. 2022 Academic Article GET IT
Times cited: 32
Aberrant T-cell exhaustion in severe combined immunodeficiency survivors with poor T-cell reconstitution after transplantation. The Journal of allergy and clinical immunology. 2022 Academic Article GET IT
Dominant epitopes presented by prevalent HLA alleles permit wide use of banked CMVpp65 T-cells in adoptive therapy. Blood advances. 2022 Academic Article GET IT
Early intestinal microbial features are associated with CD4 T-cell recovery after allogeneic hematopoietic transplant. Blood. 2022 Academic Article GET IT
Times cited: 27
A TCR mimic monoclonal antibody reactive with the "public" phospho-neoantigen pIRS2/HLA-A*02:01 complex. JCI insight. 2022 Academic Article GET IT
Times cited: 8
The Simplified Comorbidity Index: a new tool for prediction of nonrelapse mortality in allo-HCT. Blood advances. 2022 Academic Article GET IT
Times cited: 20
Antithymocyte globulin exposure in CD34+ T-cell-depleted allogeneic hematopoietic cell transplantation. Blood advances. 2022 Academic Article GET IT
Allogeneic Tumor Antigen-Specific T Cells for Broadly Applicable Adoptive Cell Therapy of Cancer. Cancer treatment and research. 2022 Academic Article GET IT
Times cited: 1
Randomized Phase III BMT CTN Trial of Calcineurin Inhibitor-Free Chronic Graft-Versus-Host Disease Interventions in Myeloablative Hematopoietic Cell Transplantation for Hematologic Malignancies. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2021 Academic Article GET IT
Times cited: 80
Phase I dose escalation safety and feasibility study of autologous WT1-sensitized T cells for the treatment of patients with recurrent ovarian cancer. Journal for immunotherapy of cancer. 2021 Academic Article GET IT
Donor-Host Lineage-Specific Chimerism Monitoring and Analysis in Pediatric Patients Following Allogeneic Stem Cell Transplantation: Influence of Pretransplantation Variables and Correlation with Post-Transplantation Outcomes. Transplantation and cellular therapy. 2021 Academic Article GET IT
Times cited: 9
Universal Engraftment after Allogeneic Hematopoietic Cell Transplantation Using Cryopreserved CD34-Selected Grafts. Transplantation and cellular therapy. 2021 Academic Article GET IT
Ocular Outcomes after Treatment of Cytomegalovirus Retinitis Using Adoptive Immunotherapy with Cytomegalovirus-Specific Cytotoxic T Lymphocytes. Ophthalmology. Retina. 2021 Academic Article GET IT
Times cited: 13
Development and validation of a disease risk stratification system for patients with haematological malignancies: a retrospective cohort study of the European Society for Blood and Marrow Transplantation registry. The Lancet. Haematology. 2021 Academic Article GET IT
Times cited: 25
Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors. Nature cancer. 2021 Academic Article GET IT
Times cited: 95
CD4+ T-cell reconstitution predicts survival outcomes after acute graft-versus-host-disease: a dual-center validation. Blood. 2021 Academic Article GET IT
Times cited: 34
Adoptive therapy with CMV-specific cytotoxic T lymphocytes depends on baseline CD4+ immunity to mediate durable responses. Blood advances. 2021 Academic Article GET IT
Times cited: 26
High progression-free survival after intermediate intensity double unit cord blood transplantation in adults. Blood advances. 2020 Academic Article GET IT
Times cited: 33
Combining the Disease Risk Index and Hematopoietic Cell Transplant Co-Morbidity Index provides a comprehensive prognostic model for CD34⁺-selected allogeneic transplantation. Advances in cell and gene therapy. 2020 Academic Article GET IT
Early CD4+ T cell reconstitution as predictor of outcomes after allogeneic hematopoietic cell transplantation. Cytotherapy. 2020 Academic Article GET IT
Times cited: 32
Engraftment kinetics after transplantation of double unit cord blood grafts combined with haplo-identical CD34+ cells without antithymocyte globulin. Leukemia. 2020 Academic Article GET IT
Times cited: 10
Epigenetic reprogramming sensitizes immunologically silent EBV+ lymphomas to virus-directed immunotherapy. Blood. 2020 Academic Article GET IT
Times cited: 44
DNA methylation enzymes and PRC1 restrict B-cell Epstein-Barr virus oncoprotein expression. Nature microbiology. 2020 Academic Article GET IT
Times cited: 33
Low toxicity and favorable overall survival in relapsed/refractory B-ALL following CAR T cells and CD34-selected T-cell depleted allogeneic hematopoietic cell transplant. Bone marrow transplantation. 2020 Academic Article GET IT
Times cited: 11
Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation. The Journal of clinical investigation. 2020 Academic Article GET IT
Times cited: 176
Toxicity and response after CD19-specific CAR T-cell therapy in pediatric/young adult relapsed/refractory B-ALL. Blood. 2019 Academic Article GET IT
Times cited: 195
Ex Vivo T Cell-Depleted Hematopoietic Stem Cell Transplantation for Adult Patients with Acute Myelogenous Leukemia in First and Second Remission: Long-Term Disease-Free Survival with a Significantly Reduced Risk of Graft-versus-Host Disease. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2019 Academic Article GET IT
Times cited: 21
Presalvage International Staging System Stage and Other Important Outcome Associations in CD34⁺-Selected Allogeneic Hematopoietic Stem Cell Transplantation for Multiple Myeloma. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2019 Academic Article GET IT
Times cited: 9
Therapeutic advantages provided by banked virus-specific T-cells of defined HLA-restriction. Bone marrow transplantation. 2019 Review GET IT
Times cited: 19
Standard Antithymocyte Globulin Dosing Results in Poorer Outcomes in Overexposed Patients after Ex Vivo CD34⁺ Selected Allogeneic Hematopoietic Cell Transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2019 Academic Article GET IT
Times cited: 15
Immune Cytopenias after Ex Vivo CD34+-Selected Allogeneic Hematopoietic Cell Transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2019 Academic Article GET IT
Times cited: 8
Ex vivo and in vivo T cell-depleted allogeneic stem cell transplantation in patients with acute myeloid leukemia in first complete remission resulted in similar overall survival: on behalf of the ALWP of the EBMT and the MSKCC. Journal of hematology & oncology. 2018 Academic Article GET IT
Times cited: 16
SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery. Blood. 2018 Academic Article GET IT
Times cited: 129
Early Fluid Overload Is Associated with an Increased Risk of Nonrelapse Mortality after Ex Vivo CD34-Selected Allogeneic Hematopoietic Cell Transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2018 Academic Article GET IT
Times cited: 14
Adoptive immunotherapy with haploidentical natural killer cells and Anti-GD2 monoclonal antibody m3F8 for resistant neuroblastoma: Results of a phase I study. Oncoimmunology. 2018 Academic Article GET IT
Times cited: 66
B-cell differentiation and IL-21 response in IL2RG/JAK3 SCID patients after hematopoietic stem cell transplantation. Blood. 2018 Academic Article GET IT
Times cited: 35
Allogeneic Matched Related Donor Bone Marrow Transplantation for Pediatric Patients With Severe Aplastic Anemia Using "Low-dose" Cyclophosphamide, ATG Plus Fludarabine. Journal of pediatric hematology/oncology. 2018 Academic Article GET IT
TCR-mimic bispecific antibodies targeting LMP2A show potent activity against EBV malignancies. JCI insight. 2018 Academic Article GET IT
Times cited: 34
Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndrome: Comparison of Outcomes between CD34⁺ Selected and Unmodified Hematopoietic Stem Cell Transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2018 Academic Article GET IT
Times cited: 19
Immune reconstitution and survival of 100 SCID patients post-hematopoietic cell transplant: a PIDTC natural history study. Blood. 2017 Academic Article GET IT
Times cited: 193
Long-term prognosis for 1-year relapse-free survivors of CD34+ cell-selected allogeneic hematopoietic stem cell transplantation: a landmark analysis. Bone marrow transplantation. 2017 Academic Article GET IT
Times cited: 8
Impact of Toxicity on Survival for Older Adult Patients after CD34⁺ Selected Allogeneic Hematopoietic Stem Cell Transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2017 Academic Article GET IT
Times cited: 13
Effects of Late Toxicities on Outcomes in Long-Term Survivors of Ex-Vivo CD34⁺-Selected Allogeneic Hematopoietic Cell Transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2017 Academic Article GET IT
Times cited: 11
In vivo immuno-targeting of an extracellular epitope of membrane bound preferentially expressed antigen in melanoma (PRAME). Oncotarget. 2017 Academic Article GET IT
Times cited: 19
T Cell Depletion as an Alternative Approach for Patients 55 Years or Older Undergoing Allogeneic Stem Cell Transplantation as Curative Therapy for Hematologic Malignancies. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2017 Academic Article GET IT
Times cited: 8
The Impact of Toxicities on First-Year Outcomes after Ex Vivo CD34⁺-Selected Allogeneic Hematopoietic Cell Transplantation in Adults with Hematologic Malignancies. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2017 Academic Article GET IT
Times cited: 9
A Chemotherapy-Only Regimen of Busulfan, Melphalan, and Fludarabine, and Rabbit Antithymocyte Globulin Followed by Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplantations for the Treatment of Myeloid Malignancies. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2017 Academic Article GET IT
Times cited: 6
Allogeneic Hematopoietic Stem Cell Transplantation with Myeloablative Conditioning Is Associated with Favorable Outcomes in Mixed Phenotype Acute Leukemia. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2017 Academic Article GET IT
Times cited: 12
Intrathymic injection of hematopoietic progenitor cells establishes functional T cell development in a mouse model of severe combined immunodeficiency. Journal of hematology & oncology. 2017 Academic Article GET IT
Times cited: 10
Radiation-free, alternative-donor HCT for Fanconi anemia patients: results from a prospective multi-institutional study. Blood. 2017 Academic Article GET IT
Times cited: 67
Early recovery of T-cell function predicts improved survival after T-cell depleted allogeneic transplant. Leukemia & lymphoma. 2017 Academic Article GET IT
Times cited: 50
Ex Vivo CD34⁺-Selected T Cell-Depleted Peripheral Blood Stem Cell Grafts for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Leukemia and Myelodysplastic Syndrome Is Associated with Low Incidence of Acute and Chronic Graft-versus-Host Disease and High Treatment Response. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2016 Academic Article GET IT
Times cited: 33
Hematopoietic Cell Transplantation Comorbidity Index Predicts Outcomes in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes Receiving CD34⁺ Selected Grafts for Allogeneic Hematopoietic Cell Transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2016 Academic Article GET IT
Times cited: 22
Allogeneic hematopoietic stem cell transplantation for nonmalignant hematologic disorders using chemotherapy-only cytoreductive regimens and T-cell-depleted grafts from human leukocyte antigen-matched or -mismatched donors. Pediatric hematology and oncology. 2016 Academic Article GET IT
Times cited: 3
Soluble and membrane-bound interleukin (IL)-15 Rα/IL-15 complexes mediate proliferation of high-avidity central memory CD8⁺ T cells for adoptive immunotherapy of cancer and infections. Clinical and experimental immunology. 2016 Academic Article GET IT
Times cited: 31
Second Allogeneic Stem Cell Transplantation for Acute Leukemia Using a Chemotherapy-Only Cytoreduction with Clofarabine, Melphalan, and Thiotepa. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2016 Academic Article GET IT
Times cited: 10
Virus-specific T-cell banks for 'off the shelf' adoptive therapy of refractory infections. Bone marrow transplantation. 2016 Information Resource GET IT
Times cited: 127
Late effects in patients with Fanconi anemia following allogeneic hematopoietic stem cell transplantation from alternative donors. Bone marrow transplantation. 2016 Academic Article GET IT
Times cited: 42
Characterization of a c-Rel Inhibitor That Mediates Anticancer Properties in Hematologic Malignancies by Blocking NF-κB-Controlled Oxidative Stress Responses. Cancer research. 2016 Academic Article GET IT
Times cited: 34
Artificial Antigen Presenting Cells: An Off the Shelf Approach for Generation of Desirable T-Cell Populations for Broad Application of Adoptive Immunotherapy. Advancements in genetic engineering. 2015 Academic Article GET IT
Therapeutic bispecific T-cell engager antibody targeting the intracellular oncoprotein WT1. Nature biotechnology. 2015 Academic Article GET IT
Times cited: 132
High Disease-Free Survival with Enhanced Protection against Relapse after Double-Unit Cord Blood Transplantation When Compared with T Cell-Depleted Unrelated Donor Transplantation in Patients with Acute Leukemia and Chronic Myelogenous Leukemia. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2015 Academic Article GET IT
Times cited: 37
CD34-Selected Hematopoietic Stem Cell Transplants Conditioned with Myeloablative Regimens and Antithymocyte Globulin for Advanced Myelodysplastic Syndrome: Limited Graft-versus-Host Disease without Increased Relapse. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2015 Academic Article GET IT
Times cited: 44
CHZ868, a Type II JAK2 Inhibitor, Reverses Type I JAK Inhibitor Persistence and Demonstrates Efficacy in Myeloproliferative Neoplasms. Cancer cell. 2015 Academic Article GET IT
Times cited: 126
Immunotherapy with Donor T Cells Sensitized with Overlapping Pentadecapeptides for Treatment of Persistent Cytomegalovirus Infection or Viremia. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2015 Academic Article GET IT
Times cited: 76
Affinity maturation of T-cell receptor-like antibodies for Wilms tumor 1 peptide greatly enhances therapeutic potential. Leukemia. 2015 Academic Article GET IT
Times cited: 74
Late complications of mixed chimerism following allogeneic bone marrow transplantation for thalassemia major. Pediatric blood & cancer. 2015 Article GET IT
Times cited: 5
Intensified Mycophenolate Mofetil Dosing and Higher Mycophenolic Acid Trough Levels Reduce Severe Acute Graft-versus-Host Disease after Double-Unit Cord Blood Transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2015 Academic Article GET IT
Times cited: 32
Comparison of outcomes at two institutions of patients with ALL receiving ex vivo T-cell-depleted or unmodified allografts. Bone marrow transplantation. 2015 Academic Article GET IT
Times cited: 32
High day 28 ST2 levels predict for acute graft-versus-host disease and transplant-related mortality after cord blood transplantation. Blood. 2014 Academic Article GET IT
Times cited: 91
Human herpesvirus 6B immediate-early I protein contains functional HLA-A*02, HLA-A*03, and HLA-B*07 class I restricted CD8(+) T-cell epitopes. European journal of immunology. 2014 Academic Article GET IT
Times cited: 10
Incidence, nature and mortality of cytomegalovirus infection after double-unit cord blood transplant. Leukemia & lymphoma. 2014 Academic Article GET IT
Times cited: 24
Transplantation outcomes for severe combined immunodeficiency, 2000-2009. The New England journal of medicine. 2014 Academic Article GET IT
Times cited: 592
Therapeutic efficacy of an Fc-enhanced TCR-like antibody to the intracellular WT1 oncoprotein. Clinical cancer research : an official journal of the American Association for Cancer Research. 2014 Academic Article GET IT
Times cited: 45
A TCR-mimic antibody to WT1 bypasses tyrosine kinase inhibitor resistance in human BCR-ABL+ leukemias. Blood. 2014 Academic Article GET IT
Times cited: 43
Cancer-testis antigen 7 expression and immune responses following allogeneic stem cell transplantation for multiple myeloma. Cancer immunology research. 2014 Academic Article GET IT
Times cited: 11
A small-molecule c-Rel inhibitor reduces alloactivation of T cells without compromising antitumor activity. Cancer discovery. 2014 Academic Article GET IT
Times cited: 48
Frequent human herpesvirus-6 viremia but low incidence of encephalitis in double-unit cord blood recipients transplanted without antithymocyte globulin. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2014 Academic Article GET IT
Times cited: 42
Establishing diagnostic criteria for severe combined immunodeficiency disease (SCID), leaky SCID, and Omenn syndrome: the Primary Immune Deficiency Treatment Consortium experience. The Journal of allergy and clinical immunology. 2013 Academic Article GET IT
Times cited: 262
Primary Immune Deficiency Treatment Consortium (PIDTC) report. The Journal of allergy and clinical immunology. 2013 Academic Article GET IT
Times cited: 49
Allelic polymorphisms of inhibitory killer immunoglobulin-like receptor natural killer cell function can also influence the graft-versus-leukemia response. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2013 Editorial Article GET IT
Times cited: 2
Ten-year follow-up of pediatric patients with non-Hodgkin lymphoma treated with allogeneic or autologous stem cell transplantation. Pediatric blood & cancer. 2013 Academic Article GET IT
Times cited: 25
A recessive founder mutation in regulator of telomere elongation helicase 1, RTEL1, underlies severe immunodeficiency and features of Hoyeraal Hreidarsson syndrome. PLoS genetics. 2013 Academic Article GET IT
Times cited: 105
The natural history of children with severe combined immunodeficiency: baseline features of the first fifty patients of the primary immune deficiency treatment consortium prospective study 6901. Journal of clinical immunology. 2013 Academic Article GET IT
Times cited: 87
Targeting the intracellular WT1 oncogene product with a therapeutic human antibody. Science translational medicine. 2013 Academic Article GET IT
Times cited: 153
Ex vivo T cell-depleted versus unmodified allografts in patients with acute myeloid leukemia in first complete remission. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2013 Academic Article GET IT
Times cited: 81
Graft-versus-host disease after double-unit cord blood transplantation has unique features and an association with engrafting unit-to-recipient HLA match. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2013 Academic Article GET IT
Times cited: 58
WT1-specific T-cell responses in high-risk multiple myeloma patients undergoing allogeneic T cell-depleted hematopoietic stem cell transplantation and donor lymphocyte infusions. Blood. 2012 Academic Article GET IT
Times cited: 61
T cell-depleted stem cell transplantation for adults with high-risk acute lymphoblastic leukemia: long-term survival for patients in first complete remission with a decreased risk of graft-versus-host disease. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2012 Academic Article GET IT
Times cited: 37
Comparative outcomes of donor graft CD34+ selection and immune suppressive therapy as graft-versus-host disease prophylaxis for patients with acute myeloid leukemia in complete remission undergoing HLA-matched sibling allogeneic hematopoietic cell transplantation. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2012 Academic Article GET IT
Times cited: 136
Mapping of novel peptides of WT-1 and presenting HLA alleles that induce epitope-specific HLA-restricted T cells with cytotoxic activity against WT-1(+) leukemias. Blood. 2012 Academic Article GET IT
Times cited: 49
Paroxysmal nocturnal hemoglobinuria in pediatric patients. Pediatric blood & cancer. 2011 Academic Article GET IT
Times cited: 30
Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantation. Blood. 2011 Academic Article GET IT
Times cited: 351
Allogeneic hematopoietic stem cell transplantation for pediatric patients with treatment-related myelodysplastic syndrome or acute myelogenous leukemia. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2011 Academic Article GET IT
Times cited: 14
Novel strategies for adoptive therapy following HLA disparate transplants. Best practice & research. Clinical haematology. 2011 Information Resource GET IT
Times cited: 9
Characteristics of CliniMACS® System CD34-enriched T cell-depleted grafts in a multicenter trial for acute myeloid leukemia-Blood and Marrow Transplant Clinical Trials Network (BMT CTN) protocol 0303. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2011 Academic Article GET IT
Times cited: 55
T-cell-depleted hematopoietic SCT from unrelated donors for the treatment of congenital amegakaryocytic thrombocytopenia. Bone marrow transplantation. 2011 Article GET IT
Times cited: 8
Low risk of chronic graft-versus-host disease and relapse associated with T cell-depleted peripheral blood stem cell transplantation for acute myelogenous leukemia in first remission: results of the blood and marrow transplant clinical trials network protocol 0303. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2011 Academic Article GET IT
Times cited: 124
Reduced late mortality risk contributes to similar survival after double-unit cord blood transplantation compared with related and unrelated donor hematopoietic stem cell transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2011 Academic Article GET IT
Times cited: 66
T cell-depleted unrelated donor stem cell transplantation provides favorable disease-free survival for adults with hematologic malignancies. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2011 Academic Article GET IT
Times cited: 67
An in vivo model of double-unit cord blood transplantation that correlates with clinical engraftment. Blood. 2010 Academic Article GET IT
Times cited: 44
Adoptive transfer of unselected or leukemia-reactive T-cells in the treatment of relapse following allogeneic hematopoietic cell transplantation. Seminars in immunology. 2010 Information Resource GET IT
Times cited: 28
Hematopoietic stem cell transplantation for severe combined immune deficiency or what the children have taught us. Immunology and allergy clinics of North America. 2010 Information Resource GET IT
Times cited: 4
Second-line age-adjusted International Prognostic Index in patients with advanced non-Hodgkin lymphoma after T-cell depleted allogeneic hematopoietic SCT. Bone marrow transplantation. 2010 Academic Article GET IT
Times cited: 21
Autonomous growth potential of leukemia blast cells is associated with poor prognosis in human acute leukemias. Journal of hematology & oncology. 2009 Academic Article GET IT
Times cited: 12
Artificial antigen presenting cells that express prevalent HLA alleles: A step towards the broad application of antigen-specific adoptive cell therapies. Discovery medicine. 2009 Information Resource GET IT
Times cited: 6
Improving cellular therapy for primary immune deficiency diseases: recognition, diagnosis, and management. The Journal of allergy and clinical immunology. 2009 Academic Article GET IT
Times cited: 105
KIR and HLA genotypes are associated with disease progression and survival following autologous hematopoietic stem cell transplantation for high-risk neuroblastoma. Clinical cancer research : an official journal of the American Association for Cancer Research. 2009 Academic Article GET IT
Times cited: 106
A panel of artificial APCs expressing prevalent HLA alleles permits generation of cytotoxic T cells specific for both dominant and subdominant viral epitopes for adoptive therapy. Journal of immunology (Baltimore, Md. : 1950). 2009 Academic Article GET IT
Times cited: 28
Breaking tolerance to self, circulating natural killer cells expressing inhibitory KIR for non-self HLA exhibit effector function after T cell-depleted allogeneic hematopoietic cell transplantation. Blood. 2009 Academic Article GET IT
Times cited: 114
Use of humanized severe combined immunodeficient mice for human vaccine development. Expert review of vaccines. 2009 Information Resource GET IT
Times cited: 31
Allogeneic hematopoietic cell transplantation for primary immune deficiency diseases: current status and critical needs. The Journal of allergy and clinical immunology. 2008 Academic Article GET IT
Times cited: 61
Response to pneumococcal (PNCRM7) and haemophilus influenzae conjugate vaccines (HIB) in pediatric and adult recipients of an allogeneic hematopoietic cell transplantation (alloHCT). Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2008 Academic Article GET IT
Times cited: 60
Transplantation in remission improves the disease-free survival of patients with advanced myelodysplastic syndromes treated with myeloablative T cell-depleted stem cell transplants from HLA-identical siblings. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2008 Academic Article GET IT
Times cited: 59
In vivo imaging and quantitation of adoptively transferred human antigen-specific T cells transduced to express a human norepinephrine transporter gene. Cancer research. 2007 Academic Article GET IT
Times cited: 61
Fludarabine-based conditioning secures engraftment of second hematopoietic stem cell allografts (HSCT) in the treatment of initial graft failure. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2007 Academic Article GET IT
Times cited: 38
T cell depleted stem-cell transplantation for adults with hematologic malignancies: sustained engraftment of HLA-matched related donor grafts without the use of antithymocyte globulin. Blood. 2007 Academic Article GET IT
Times cited: 103
Predictors for persistent cytomegalovirus reactivation after T-cell-depleted allogeneic hematopoietic stem cell transplantation. Transplant infectious disease : an official journal of the Transplantation Society. 2007 Academic Article GET IT
Times cited: 36
Final height in pediatric patients after hyperfractionated total body irradiation and stem cell transplantation. Bone marrow transplantation. 2007 Academic Article GET IT
Times cited: 41
Intravenous busulfan and melphalan, tacrolimus, and short-course methotrexate followed by unmodified HLA-matched related or unrelated hematopoietic stem cell transplantation for the treatment of advanced hematologic malignancies. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2007 Academic Article GET IT
Times cited: 24
A phase 1/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies. Blood. 2006 Academic Article GET IT
Times cited: 256
Immunogenicity of recombinant hepatitis B vaccine (rHBV) in recipients of unrelated or related allogeneic hematopoietic cell (HC) transplants. Blood. 2006 Academic Article GET IT
Times cited: 61
[131I]FIAU labeling of genetically transduced, tumor-reactive lymphocytes: cell-level dosimetry and dose-dependent toxicity. European journal of nuclear medicine and molecular imaging. 2006 Academic Article GET IT
Times cited: 27
TLR1 and TLR6 polymorphisms are associated with susceptibility to invasive aspergillosis after allogeneic stem cell transplantation. Annals of the New York Academy of Sciences. 2005 Academic Article GET IT
Times cited: 171
Rituximab therapy of lymphoma is enhanced by orally administered (1-->3),(1-->4)-D-beta-glucan. Leukemia research. 2005 Academic Article GET IT
Times cited: 61
Intra-thymic/splenic engraftment of human T cells in HLA-DR1 transgenic NOD/scid mice. Cellular immunology. 2005 Academic Article GET IT
Times cited: 8
Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes. Blood. 2005 Academic Article GET IT
Times cited: 421
In vitro stimulation with WT1 peptide-loaded Epstein-Barr virus-positive B cells elicits high frequencies of WT1 peptide-specific T cells with in vitro and in vivo tumoricidal activity. Clinical cancer research : an official journal of the American Association for Cancer Research. 2004 Academic Article GET IT
Times cited: 46
Generation of CMV-specific T lymphocytes using protein-spanning pools of pp65-derived overlapping pentadecapeptides for adoptive immunotherapy. Blood. 2004 Academic Article GET IT
Times cited: 75
Wilms Tumor Gene (WT1) and p53 expression in endometrial carcinomas: a study of 130 cases using a tissue microarray. Gynecologic oncology. 2004 Academic Article GET IT
Times cited: 72
Targeted deletion of T-cell clones using alpha-emitting suicide MHC tetramers. Blood. 2004 Academic Article GET IT
Times cited: 27
Increased plasma levels of stromal-derived factor-1 (SDF-1/CXCL12) enhance human thrombopoiesis and mobilize human colony-forming cells (CFC) in NOD/SCID mice. Experimental hematology. 2004 Academic Article GET IT
Times cited: 49
Evasion from NK cell immunity by MHC class I chain-related molecules expressing colon adenocarcinoma. Journal of immunology (Baltimore, Md. : 1950). 2003 Academic Article GET IT
Times cited: 253
Robert Alan Good, MD, PhD. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2003 Academic Article GET IT
Times cited: 1
Cytoreduction with iodine-131-anti-CD33 antibodies before bone marrow transplantation for advanced myeloid leukemias. Bone marrow transplantation. 2003 Academic Article GET IT
Times cited: 87
Insulin-like growth factor-I enhances lymphoid and myeloid reconstitution after allogeneic bone marrow transplantation. Transplantation. 2003 Academic Article GET IT
Times cited: 50
Serial in vivo imaging of the targeted migration of human HSV-TK-transduced antigen-specific lymphocytes. Nature biotechnology. 2003 Academic Article GET IT
Times cited: 197
Killer Ig-like receptor haplotype analysis by gene content: evidence for genomic diversity with a minimum of six basic framework haplotypes, each with multiple subsets. Journal of immunology (Baltimore, Md. : 1950). 2002 Academic Article GET IT
Times cited: 344
Direct evidence for new T-cell generation by patients after either T-cell-depleted or unmodified allogeneic hematopoietic stem cell transplantations. Blood. 2002 Academic Article GET IT
Times cited: 148
Quantitation, selection, and functional characterization of Epstein-Barr virus-specific and alloreactive T cells detected by intracellular interferon-gamma production and growth of cytotoxic precursors. Blood. 2002 Academic Article GET IT
Times cited: 52
Rapid selection of antigen-specific T lymphocytes by retroviral transduction. Blood. 2000 Academic Article GET IT
Times cited: 51
Longitudinal monitoring of immune reconstitution by CDR3 size spectratyping after T-cell-depleted allogeneic bone marrow transplant and the effect of donor lymphocyte infusions on T-cell repertoire. Blood. 2000 Academic Article GET IT
Times cited: 89
T-cell depletion of bone marrow transplants for leukemia from donors other than HLA-identical siblings: advantage of T-cell antibodies with narrow specificities. Blood. 2000 Academic Article GET IT
Times cited: 129
Disseminated toxoplasmosis following T cell-depleted related and unrelated bone marrow transplantation. Bone marrow transplantation. 2000 Academic Article GET IT
Times cited: 45
Stem cell transplantation in patients with severe congenital neutropenia without evidence of leukemic transformation. Blood. 2000 Academic Article GET IT
Times cited: 118
Engraftment and growth of patient-derived retinoblastoma tumour in severe combined immunodeficiency mice. European journal of cancer. 2000 Academic Article GET IT
Times cited: 9
The probability of HLA-C matching between patient and unrelated donor at the molecular level: estimations based on the linkage disequilibrium between DNA typed HLA-B and HLA-C alleles. Transplantation. 1999 Academic Article GET IT
Times cited: 27
Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts. Nature. 1999 Academic Article GET IT
Times cited: 752
Comparison of immune reconstitution after unrelated and related T-cell-depleted bone marrow transplantation: effect of patient age and donor leukocyte infusions. Blood. 1999 Academic Article GET IT
Times cited: 387
Allogeneic bone marrow transplantation versus chemotherapy for the treatment of childhood acute lymphoblastic leukemia in second remission: a single-institution study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1999 Academic Article GET IT
Times cited: 55
DNA typing for HLA-A and HLA-B identifies disparities between patients and unrelated donors matched by HLA-A and HLA-B serology and HLA-DRB1. Blood. 1999 Academic Article GET IT
Times cited: 38
HLA-C disparity between patients and unrelated donors matched for HLA-A, -B, and -DRB1 alleles: impact of serological vs. DNA typing for HLA-A and -B loci. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 1999 Academic Article GET IT
Times cited: 10
Antileukemia activity of a natural killer cell line against human leukemias. Clinical cancer research : an official journal of the American Association for Cancer Research. 1998 Academic Article GET IT
Times cited: 118
Differential growth patterns in SCID mice of patient-derived chronic myelogenous leukemias. Bone marrow transplantation. 1998 Academic Article GET IT
Times cited: 8
Bone marrow transplantation for homozygous beta-thalassemia. The Memorial Sloan-Kettering Cancer Center experience. Annals of the New York Academy of Sciences. 1998 Academic Article GET IT
Times cited: 34
High-dose induction chemoradiotherapy followed by autologous bone marrow transplantation as consolidation therapy in rhabdomyosarcoma, extraosseous Ewing's sarcoma, and undifferentiated sarcoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1998 Academic Article GET IT
T-cell-depleted allogeneic bone marrow transplantation as postremission therapy for acute myelogenous leukemia: freedom from relapse in the absence of graft-versus-host disease. Blood. 1998 Academic Article GET IT
Times cited: 180
Survival of patients with chronic myelogenous leukaemia relapsing after bone marrow transplantation: comparison with patients receiving conventional chemotherapy. British journal of haematology. 1997 Academic Article GET IT
Times cited: 6
Correction of defective expression in MHC class II deficiency (bare lymphocyte syndrome) cells by retroviral transduction of CIITA. Journal of immunology (Baltimore, Md. : 1950). 1997 Academic Article GET IT
Times cited: 22
Foundation for the Accreditation of Hematopoietic Cell Therapy (FAHCT) response to FDA (Docket no. 97N-0068). FAHCT Board of Directors. Journal of hematotherapy. 1997 Article GET IT
Risk of extramedullary relapse following allogeneic bone marrow transplantation for acute myelogenous leukemia with leukemia cutis. Bone marrow transplantation. 1997 Academic Article GET IT
Times cited: 39
Biology and adoptive cell therapy of Epstein-Barr virus-associated lymphoproliferative disorders in recipients of marrow allografts. Immunological reviews. 1997 Information Resource GET IT
Times cited: 145
Immune reconstitution following T-cell depleted bone marrow transplantation: effect of age and posttransplant graft rejection prophylaxis. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 1997 Academic Article GET IT
Times cited: 116
Toxicological and immunological evaluation of the MHC-non-restricted cytotoxic T cell line TALL-104. Cancer immunology, immunotherapy : CII. 1997 Academic Article GET IT
Times cited: 6
Growth pattern and clinical correlation of subcutaneously inoculated human primary acute leukemias in severe combined immunodeficiency mice. Blood. 1996 Academic Article GET IT
Times cited: 25
Serum levels of cytokines and secondary messages after T-cell-depleted and non-T-cell-depleted bone marrow transplantation: influence of conditioning and hematopoietic reconstitution. Transplantation. 1996 Academic Article GET IT
Times cited: 22
A novel HLA class II-independent TCR-mediated T cell activation mechanism is distinguished by the V beta specificity of the proliferating oligoclones and their capacity to generate interleukin-2. Cellular immunology. 1996 Academic Article GET IT
Times cited: 4
The development of cellular immunity to Epstein-Barr virus after allogeneic bone marrow transplantation. Blood. 1996 Academic Article GET IT
Times cited: 166
Human Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes home preferentially to and induce selective regressions of autologous EBV-induced B cell lymphoproliferations in xenografted C.B-17 scid/scid mice. The Journal of experimental medicine. 1996 Academic Article GET IT
Times cited: 72
Administration of rabbit anti-asialo GM1 antiserum facilitates the development of human Epstein-Barr virus-induced lymphoproliferations in xenografted C.B-17 scid/scid mice. Transplantation. 1996 Academic Article GET IT
Times cited: 17
Adoptive cell therapy with donor lymphocytes for EBV-associated lymphomas developing after allogeneic marrow transplants. Important advances in oncology. 1996 Information Resource GET IT
Times cited: 37
Interleukin-1 production following T-cell-depleted and unmodified marrow grafts. Pediatric hematology and oncology. 1996 Academic Article GET IT
Times cited: 6
Selective treatment of SCID mice bearing methotrexate-transport-resistant human acute lymphoblastic leukemia tumors with trimetrexate and leucovorin protection. Blood. 1995 Academic Article GET IT
Times cited: 26
Adoptive immunotherapy using donor leukocytes following bone marrow transplantation for chronic myeloid leukemia: is T cell dose important in determining biological response?. Bone marrow transplantation. 1995 Academic Article GET IT
Times cited: 74
Enrichment of peripheral blood stem cells in a primate model following administration of a single dose of rh-IL-1 beta. Bone marrow transplantation. 1994 Academic Article GET IT
Times cited: 10
Phase I study of recombinant human interleukin-1 beta (rhIL-1 beta) in patients with bone marrow failure. Bone marrow transplantation. 1994 Academic Article GET IT
Times cited: 13
Granulocyte colony-stimulating factor (CSF) but not interleukin-1 (IL-1), IL-3, and granulocyte-macrophage CSF protect bone marrow progenitor cells from suppression by allosensitized cytotoxic T cells. Blood. 1994 Academic Article GET IT
Times cited: 5
ICAM-1 (CD54) expression on B lymphocytes is associated with their costimulatory function and can be increased by coactivation with IL-1 and IL-7. Cellular immunology. 1994 Academic Article GET IT
Times cited: 20
Minimal residual disease is more common in patients who have mixed T-cell chimerism after bone marrow transplantation for chronic myelogenous leukemia. Blood. 1994 Academic Article GET IT
Times cited: 171
Bone marrow transplantation for thalassemia. The USA experience. The American journal of pediatric hematology/oncology. 1994 Academic Article GET IT
Times cited: 39
Chemotherapy for induction of remission of childhood acute myeloid leukemia followed by marrow transplantation or multiagent chemotherapy: a report from the Childrens Cancer Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1994 Academic Article GET IT
Times cited: 89
IL-7 induces surface expression of B7/BB1 on pre-B cells and an associated increase in their costimulatory effects on T cell proliferation. Cellular immunology. 1994 Academic Article GET IT
Choice of pretransplant treatment and timing of transplants for chronic myelogenous leukemia in chronic phase. Blood. 1993 Academic Article GET IT
Times cited: 184
Treatment of Diamond-Blackfan anemia with recombinant human interleukin-3. Blood. 1993 Academic Article GET IT
Times cited: 45
Successful treatment of Diamond-Blackfan anemia with interleukin 3. Stem cells (Dayton, Ohio). 1993 Academic Article GET IT
Times cited: 5
Dissection of the function of HLA class II and costimulation in B cell-mediated and toxic shock syndrome toxin-1-induced T cell proliferation. Journal of immunology (Baltimore, Md. : 1950). 1993 Academic Article GET IT
Times cited: 9
Effect of stem cell factor on in vitro erythropoiesis in patients with bone marrow failure syndromes. Blood. 1992 Academic Article GET IT
Times cited: 42
Myeloid and lymphoid chimerism after T-cell-depleted bone marrow transplantation: evaluation of conditioning regimens using the polymerase chain reaction to amplify human minisatellite regions of genomic DNA. Blood. 1992 Academic Article GET IT
Times cited: 111
Reasons that patients with acute myelogenous leukemia do not undergo allogeneic bone marrow transplantation. The New England journal of medicine. 1992 Academic Article GET IT
Times cited: 48
The AIS CELLector: a new technology for stem cell purification. Progress in clinical and biological research. 1992 Academic Article GET IT
Times cited: 14
Bone marrow transplants in patients lacking an HLA-matched sibling donor. Pediatric annals. 1991 Information Resource GET IT
Times cited: 6
Marrow transplantation from human leukocyte antigen-identical or haploidentical donors for correction of Wiskott-Aldrich syndrome. The Journal of pediatrics. 1991 Academic Article GET IT
Times cited: 47
High-dose melphalan with 6-hydroxydopamine-purged autologous bone marrow transplantation for poor-risk neuroblastoma. Cancer. 1991 Academic Article GET IT
Times cited: 18
Purification and partial characterization of a human hematopoietic precursor population. Blood. 1991 Academic Article GET IT
Times cited: 45
Characterization of the in vitro sensitivity of human lymphoid and hematopoietic progenitors to L-leucyl-L-leucine methyl ester. Transplantation. 1991 Academic Article GET IT
Times cited: 11
Myeloablative combination chemotherapy without total body irradiation for neuroblastoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1991 Academic Article GET IT
Times cited: 84
No retroviremia or pathology in long-term follow-up of monkeys exposed to a murine amphotropic retrovirus. Human gene therapy. 1991 Academic Article GET IT
Times cited: 71
Stage IV neuroblastoma more than 1 year of age at diagnosis: major response to chemotherapy and survival durations correlated strongly with dose intensity. Progress in clinical and biological research. 1991 Academic Article GET IT
Times cited: 9
B-cell differentiation following autologous, conventional, or T-cell depleted bone marrow transplantation: a recapitulation of normal B-cell ontogeny. Blood. 1990 Academic Article GET IT
Times cited: 130
Dose-intensive use of cyclophosphamide in ablation of neuroblastoma. Cancer. 1990 Academic Article GET IT
Times cited: 51
Cytotoxic and proliferative T-cell clones with antidonor reactivity from a patient transplanted for severe combined immunodeficiency disease. Human immunology. 1990 Academic Article GET IT
Times cited: 5
Evidence that appearance of thymulin in plasma follows lymphoid chimerism and precedes development of immunity in patients with lethal combined immunodeficiency transplanted with T cell-depleted haploidentical marrow. Transplantation. 1990 Academic Article GET IT
Times cited: 4
Anti-leukemia potential of interleukin-2 activated natural killer cells after bone marrow transplantation for chronic myelogenous leukemia. Blood. 1990 Academic Article GET IT
Times cited: 121
Effects of interleukin-3 on hematopoietic recovery after 5-fluorouracil or cyclophosphamide treatment of cynomolgus primates. The Journal of clinical investigation. 1990 Academic Article GET IT
Times cited: 50
High levels of granulocyte and granulocyte-macrophage colony-stimulating factors in cord blood of normal full-term neonates. The Journal of pediatrics. 1990 Academic Article GET IT
Times cited: 74
Use of an anti-pan T-lymphocyte ricin a chain immunotoxin in steroid-resistant acute graft-versus-host disease. Blood. 1990 Academic Article GET IT
Times cited: 98
Cytogenetic analysis of chimerism and leukemia relapse in chronic myelogenous leukemia patients after T cell-depleted bone marrow transplantation. Blood. 1990 Academic Article GET IT
Times cited: 86
Autografting with bone marrow exposed to multiple courses of very high dose cyclophosphamide in vivo and to 4-hydroperoxycyclophosphamide in vitro. Medical and pediatric oncology. 1990 Academic Article GET IT
Times cited: 8
Effects of hematopoietic growth factors following myeloablation in a primate model. International journal of cell cloning. 1990 Academic Article GET IT
Times cited: 2
Total body irradiation for bone marrow transplantation: the Memorial Sloan-Kettering Cancer Center experience. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 1990 Academic Article GET IT
Times cited: 51
Detection of posttransplant minimal disease chronic myelogenous leukemia by bcr rearrangement analysis. Cancer genetics and cytogenetics. 1989 Academic Article GET IT
Times cited: 2
Graft failure after T-cell-depleted human leukocyte antigen identical marrow transplants for leukemia: II. In vitro analyses of host effector mechanisms. Blood. 1989 Academic Article GET IT
Times cited: 71
Loss of tolerance associated with disappearance of B cells in a patient sequentially transplanted with paternal and maternal bone marrow for the treatment of severe combined immunodeficiency disease. Human immunology. 1989 Academic Article GET IT
Times cited: 6
Retroviral vector-mediated high-efficiency expression of adenosine deaminase (ADA) in hematopoietic long-term cultures of ADA-deficient marrow cells. Proceedings of the National Academy of Sciences of the United States of America. 1989 Academic Article GET IT
Times cited: 66
Effects of interleukin-1 on hematopoietic progenitors: evidence of stimulatory and inhibitory activities in a primate model. Blood. 1989 Academic Article GET IT
Times cited: 54
Characterization of B cells in severe combined immunodeficiency disease. Human immunology. 1989 Academic Article GET IT
Times cited: 20
T cell depletion of human bone marrow. Comparison of Campath-1 plus complement, anti-T cell ricin A chain immunotoxin, and soybean agglutinin alone or in combination with sheep erythrocytes or immunomagnetic beads. Transplantation. 1989 Academic Article GET IT
Times cited: 53
Bare lymphocyte syndrome: altered HLA class II expression in B cell lines derived from two patients. Human immunology. 1989 Academic Article GET IT
Times cited: 55
Correlation between interleukin-1 production and engraftment of transplanted bone marrow stem cells in patients with lethal immunodeficiencies. Blood. 1989 Academic Article GET IT
Times cited: 14
Immune reconstitution following bone marrow transplantation: comparison of recipients of T-cell depleted marrow with recipients of conventional marrow grafts. Blood. 1989 Academic Article GET IT
Times cited: 215
Autologous bone marrow transplant using 4-HC, VP-16 purged bone marrow for acute non-lymphoblastic leukemia. Bone marrow transplantation. 1989 Academic Article GET IT
Times cited: 7
Effects of IL-1 on hematopoietic progenitors after myelosuppressive chemoradiotherapy. Biotherapy (Dordrecht, Netherlands). 1989 Academic Article GET IT
Times cited: 14
Optimal conditions for in vitro T cell depletion of human bone marrow by Campath-1a plus complement as demonstrated by limiting dilution analysis. Bone marrow transplantation. 1989 Academic Article GET IT
Times cited: 7
The use of HLA-non-identical T-cell-depleted marrow transplants for correction of severe combined immunodeficiency disease. Immunodeficiency reviews. 1989 Information Resource GET IT
Times cited: 123
Tolerance of engrafted donor T cells following bone marrow transplantation for severe combined immunodeficiency. Clinical immunology and immunopathology. 1988 Academic Article GET IT
Times cited: 21
In vitro interferon-gamma production by cultured T-cells in severe aplastic anaemia: correlation with granulomonopoietic inhibition in patients who respond to anti-thymocyte globulin. British journal of haematology. 1988 Academic Article GET IT
Times cited: 34
Recombinant human granulocyte-colony stimulating factor: in vivo effects on myelopoiesis in primates. Behring Institute Mitteilungen. 1988 Information Resource GET IT
Times cited: 7
Treatment of steroid-resistant acute graft-vs-host disease by in vivo administration of an anti-T-cell ricin A chain immunotoxin. 1988 GET IT
Times cited: 51
Immunosuppression prior to marrow transplantation for sensitized aplastic anemia patients: comparison of TLI with TBI. International journal of radiation oncology, biology, physics. 1988 Academic Article GET IT
Times cited: 6
Radiosensitivity of NK lytic activities and NK-mediated hematopoietic colony inhibition: effect of activation with IL-2 and blocking of the T-200 molecule. Cellular immunology. 1988 Academic Article GET IT
Times cited: 4
Proceedings of the XIVth annual meeting of the European Cooperative Group for Bone Marrow Transplantation. 10-13 April 1988, Chamonix, France. Abstracts. Bone marrow transplantation. 1988 Academic Article GET IT
Allogeneic bone marrow transplantation after hyperfractionated total-body irradiation and cyclophosphamide in children with acute leukemia. The New England journal of medicine. 1987 Academic Article GET IT
Times cited: 180
Bone marrow transplantation for acute non-lymphocytic leukemia: a report from the Childrens Cancer Study Group of sixty-seven children transplanted in first remission. Bone marrow transplantation. 1987 Academic Article GET IT
Times cited: 23
Effects of in vivo administration of human recombinant IL-2 to cynomolgus monkeys after autologous bone marrow transplantation. Transplantation proceedings. 1987 Academic Article GET IT
Times cited: 4
Effects of recombinant human granulocyte-colony stimulating factor on hematopoietic reconstitution after autologous bone marrow transplantation in primates. Transplantation proceedings. 1987 Academic Article GET IT
Times cited: 28
HLA nonidentical T cell depleted marrow transplants: a comparison of results in patients treated for leukemia and severe combined immunodeficiency disease. Transplantation proceedings. 1987 Academic Article GET IT
Times cited: 31
Host origin of the human hematopoietic microenvironment following allogeneic bone marrow transplantation. Blood. 1987 Academic Article GET IT
Times cited: 67
In vitro correlates of graft-host tolerance after HLA-matched and mismatched marrow transplants: suggestions from limiting dilution analysis. Transplantation proceedings. 1987 Academic Article GET IT
Times cited: 10
Interleukin 2-activated killer cells in patients following transplants of soybean lectin-separated and E rosette-depleted bone marrow. Blood. 1987 Academic Article GET IT
Times cited: 42
The diagnostic, prophylactic, and therapeutic uses of monoclonal antibodies to human cytomegalovirus. Transplantation proceedings. 1987 Academic Article GET IT
Times cited: 13
Interleukin-2 production and response to interleukin-2 by peripheral blood mononuclear cells from patients after bone marrow transplantation: II. Patients receiving soybean lectin-separated and T cell-depleted bone marrow. Blood. 1987 Academic Article GET IT
Times cited: 30
Graft rejection in recipients of T-cell-depleted HLA-nonidentical marrow transplants for leukemia. Identification of host-derived antidonor allocytotoxic T lymphocytes. Transplantation. 1987 Academic Article GET IT
Times cited: 249
M241 (CD1) expression on B lymphocytes. Journal of immunology (Baltimore, Md. : 1950). 1987 Academic Article GET IT
Times cited: 81
Recombinant human granulocyte colony-stimulating factor. Effects on hematopoiesis in normal and cyclophosphamide-treated primates. The Journal of experimental medicine. 1987 Academic Article GET IT
Times cited: 355
Current developments in marrow transplantation. Transplantation proceedings. 1987 Academic Article GET IT
Times cited: 12
Phenotype and functional characterization of NK and LAK cells following T-depleted bone marrow transplantation. Progress in clinical and biological research. 1987 Academic Article GET IT
Times cited: 3
Recombinant human granulocyte-colony stimulating factor: in vitro and in vivo effects on myelopoiesis. Blood cells. 1987 Academic Article GET IT
Times cited: 37
Retroviral vector-mediated gene transfer and expression in nonhuman primates following autologous bone marrow transplantation. Annals of the New York Academy of Sciences. 1987 Academic Article GET IT
Times cited: 2
Retroviral-mediated gene transfer into mammalian cells. Blood cells. 1987 Review GET IT
Times cited: 24
The role of residual host immunity in graft failures following T-cell-depleted marrow transplants for leukemia. Annals of the New York Academy of Sciences. 1987 Academic Article GET IT
Times cited: 4
Clonable T lymphocytes in T cell-depleted bone marrow transplants correlate with development of graft-v-host disease. Blood. 1986 Academic Article GET IT
Times cited: 311
New promise for autologous marrow transplants in leukemia. The New England journal of medicine. 1986 Editorial Article GET IT
Times cited: 8
Natural killer cell function and interferon generation in patients with primary immunodeficiencies. Clinical immunology and immunopathology. 1986 Academic Article GET IT
Times cited: 27
Association of circulating immune complexes containing bovine proteins and graft-versus-host disease. Clinical and experimental immunology. 1986 Academic Article GET IT
Times cited: 2
Reconstitution of in vitro humoral immune function in bone marrow transplant recipients. Immunobiology. 1986 Academic Article GET IT
Evaluation of HLA-haplotype disparate parental marrow grafts depleted of T lymphocytes by differential agglutination with a soybean lectin and E-rosette depletion for the treatment of severe combined immunodeficiency. Vox sanguinis. 1986 Academic Article GET IT
Times cited: 43
Quantitation of T lymphocytes in human bone marrow by a limiting dilution assay. Transplantation. 1985 Academic Article GET IT
Times cited: 48
Specific antibody-blocking activities in antilymphocyte globulin as correlates of efficacy for the treatment of aplastic anemia. Blood. 1985 Academic Article GET IT
Times cited: 17
Transplantation of HLA-mismatched marrow depleted of T-cells by lectin agglutination and E-rosette depletion. The Tokai journal of experimental and clinical medicine. 1985 Academic Article GET IT
Times cited: 12
Depletion of stromal cell elements in human marrow grafts separated by soybean agglutinin. Blood. 1985 Academic Article GET IT
Times cited: 14
Production and response to interleukin 2 in vitro and in vivo after bone marrow transplantation in mice. Journal of immunology (Baltimore, Md. : 1950). 1985 Academic Article GET IT
Times cited: 11
Effects of in vitro purging with 4-hydroperoxycyclophosphamide on the hematopoietic and microenvironmental elements of human bone marrow. Blood. 1985 Academic Article GET IT
Times cited: 65
A comparative review of the results of transplants of fully allogeneic fetal liver and HLA-haplotype mismatched, T-cell depleted marrow in the treatment of severe combined immunodeficiency. Progress in clinical and biological research. 1985 Academic Article GET IT
Times cited: 5
Lymphoma of host origin in a marrow transplant recipient in remission of acute myeloid leukemia and receiving cyclosporin A. 1985 GET IT
Times cited: 22
Treatment of immunodeficiency with interleukin-2: initial exploration. Journal of biological response modifiers. 1984 Academic Article GET IT
Times cited: 28
Autologous mixed lymphocyte reaction in man. XII. Deficiency of the autologous mixed lymphocyte reaction in patients undergoing allogeneic bone marrow transplantation. Relationship with chronic graft-versus-host disease. Journal of clinical & laboratory immunology. 1984 Academic Article GET IT
Times cited: 1
Defective interleukin 2 production in patients after bone marrow transplantation and in vitro restoration of defective T lymphocyte proliferation by highly purified interleukin 2. Blood. 1984 Academic Article GET IT
Times cited: 91
Prevention of cytomegalovirus infection by prophylaxis with an intravenous, hyperimmune, native, unmodified cytomegalovirus globulin. Randomized trial in bone marrow transplant recipients. The American journal of medicine. 1984 Academic Article GET IT
Times cited: 115
Allogeneic bone marrow transplantation for patients with acute nonlymphocytic leukemia. Blood. 1984 Academic Article GET IT
Times cited: 57
Prevention of cytomegalovirus infection in bone marrow transplant recipients by prophylaxis with an intravenous, hyperimmune cytomegalovirus globulin. Birth defects original article series. 1984 Information Resource GET IT
Times cited: 11
Antithoracic duct lymphocyte globulin. Blood. 1983 Article GET IT
Times cited: 6
Phenylbutazone-warfarin interaction in man: further stereochemical and metabolic considerations. British journal of clinical pharmacology. 1983 Academic Article GET IT
Times cited: 94
The use of T cell culture techniques to establish the presence of an intrauterine-derived maternal T cell graft in a patient with severe combined immunodeficiency (SCID). Transplantation. 1983 Academic Article GET IT
Times cited: 26
Hyperfractionated total body irradiation for bone marrow transplantation. Results in seventy leukemia patients with allogeneic transplants. International journal of radiation oncology, biology, physics. 1983 Academic Article GET IT
Times cited: 84
Antithoracic duct lymphocyte globulin therapy of severe aplastic anemia. Blood. 1983 Academic Article GET IT
Times cited: 101
Mixed lymphocyte reactions for individuals with phenotypic identity for specific HLA-B,DR determinants: the role of linkage disequilibrium and of specific DR and other class II determinants. Journal of clinical immunology. 1983 Academic Article GET IT
Times cited: 3
Allogeneic bone marrow transplantation for patients with acute lymphoblastic leukemia. Blood. 1983 Academic Article GET IT
Times cited: 76
ABH incompatible bone marrow transplantation: removal of erythrocytes by starch sedimentation. British journal of haematology. 1983 Academic Article GET IT
Times cited: 60
Circulating thymic hormone levels in severe combined immunodeficiency. Clinical and experimental immunology. 1983 Academic Article GET IT
Times cited: 11
Interleukin 2-dependent natural killer (NK) cell lines from patients with primary T cell immunodeficiencies. Journal of immunology (Baltimore, Md. : 1950). 1983 Academic Article GET IT
Times cited: 34
Effect of procarbazine and cyclophosphamide on chromosome breakage in Fanconi anemia cells: relevance to bone marrow transplantation. Cancer genetics and cytogenetics. 1983 Academic Article GET IT
Times cited: 32
Spontaneous and concanavalin A induced suppressor cell activity in patients undergoing bone marrow transplantation: relationship with acute and chronic graft versus host disease. Journal of clinical & laboratory immunology. 1983 Academic Article GET IT
Times cited: 1
Transplantation of hematopoietic cells for lethal congenital immunodeficiencies. Birth defects original article series. 1983 Academic Article GET IT
Times cited: 22
In vitro model for detection of alloreactivity between HLA-matched donor-host pairs. Preliminary evaluation as a predictor of graft-versus-host disease. Transplantation. 1982 Academic Article GET IT
Times cited: 15
Anomalous killer cells: thymus cell dependency, precursor frequency, and response to immunosuppressive therapy. Clinical immunology and immunopathology. 1982 Academic Article GET IT
Times cited: 5
Distribution of HLA genotypes in families of patients with acute leukemia. Implications for transplantation. Transplantation. 1982 Academic Article GET IT
Times cited: 16
Abnormal humoral immune responses in peripheral blood lymphocyte cultures of bone marrow transplant recipients. Proceedings of the National Academy of Sciences of the United States of America. 1982 Academic Article GET IT
Times cited: 23
T-lymphocyte reconstitution in recipients of bone marrow transplants with and without GVHD: imbalances of T-cell subpopulations having unique regulatory and cognitive functions. Blood. 1982 Academic Article GET IT
Times cited: 95
Enrichment for CFU-C from murine and human bone marrow using soybean agglutinin. Blood. 1982 Academic Article GET IT
Times cited: 29
Bone marrow transplantation: current status. Pathobiology annual. 1982 Information Resource GET IT
Times cited: 1
Prophylaxis of CMV infection in bone marrow transplant recipients by hyperimmune CMV gamma-globulin. Developments in biological standardization. 1982 Academic Article GET IT
Times cited: 11
In vitro differentiation of human marrow T cell precursors by thymic factors in severe combined immunodeficiency. Transplantation. 1981 Academic Article GET IT
Times cited: 7
Circulating thymic hormone activity in patients with primary and secondary immunodeficiency diseases. The American journal of medicine. 1981 Academic Article GET IT
Times cited: 40
Transplantation for acute leukaemia with HLA-A and B nonidentical parental marrow cells fractionated with soybean agglutinin and sheep red blood cells. 1981 GET IT
Times cited: 293
Hyperfractionated total body irradiation for bone marrow transplantation: I. Early results in leukemia patients. International journal of radiation oncology, biology, physics. 1981 Academic Article GET IT
Times cited: 101
Papovavirus excretion following marrow transplantation: incidence and association with hepatic dysfunction. Transplantation proceedings. 1981 Academic Article GET IT
Times cited: 42
Bone marrow transplantation for correction of severe aplastic anemia and primary immunodeficiency. Annals of clinical research. 1981 Information Resource GET IT
Cardiac changes with cyclophosphamide. Medical and pediatric oncology. 1981 Academic Article GET IT
Times cited: 76
Allogeneic bone marrow transplantation using stem cells fractionated by lectins: VI, in vitro analysis of human and monkey bone marrow cells fractionated by sheep red blood cells and soybean agglutinin. Lancet (London, England). 1980 Academic Article GET IT
Times cited: 79
Bone marrow transplantation in the treatment of leukemia. Clinical bulletin. 1980 Academic Article GET IT
Times cited: 2
Histocompatibility testing for clinical bone marrow transplantation and prospects for identification of donors other than HLA genotypically identical siblings. Haematology and blood transfusion. 1980 Academic Article GET IT
Times cited: 7
Association between pre-transplant natural kill and graft-versus-host disease after stem-cell transplantation. Lancet (London, England). 1979 Academic Article GET IT
Times cited: 53
Alteration in lymphoid chimerism associated with cytomegalovirus infection after bone marrow transplantation. 1979 GET IT
Times cited: 4
Use of HLA genotypically different donors in bone marrow transplantation. Transplantation proceedings. 1979 Academic Article GET IT
Times cited: 26
Severe combined immunodeficiency: transplantation approaches for patients lacking an HLA genotypically identical sibling. Transplantation proceedings. 1978 Information Resource GET IT
Times cited: 12
Chemotactic defects in severe combined immunodeficiency. The Journal of pediatrics. 1978 Academic Article GET IT
Times cited: 9
Circulating thymic-hormone activity in congenital immunodeficiency. Lancet (London, England). 1977 Academic Article GET IT
Times cited: 33
Correlation of clinical and virus-specific immune responses following levamisole therapy of recurrent herpes progenitalis. Annals of the New York Academy of Sciences. 1977 Academic Article GET IT
Times cited: 16
Cell-mediated immune responses in patients with recurrent Herpes Simplex infections. II. Infection-associated deficiency of lymphokine production in patients with recurrent herpes labialis or herpes progenitalis. Journal of immunology (Baltimore, Md. : 1950). 1977 Academic Article GET IT
Times cited: 58
Cell-mediated immune responses in recurrent herpesvirus infections. I. Lymphocyte proliferation assay. Journal of immunology (Baltimore, Md. : 1950). 1977 Academic Article GET IT
Times cited: 55
Thymic activity in severe combined immunodeficiency diseases. Proceedings of the National Academy of Sciences of the United States of America. 1977 Academic Article GET IT
Hematologic analysis of clinical bone marrow grafting evaluated by in vitro cultures. Transplantation proceedings. 1976 Academic Article GET IT
Times cited: 10
Leukocyte migration inhibitory factor (LMIF) profile in primary and secondary immunodeficiency disease. Clinical and experimental immunology. 1976 Academic Article GET IT
Times cited: 12
Relevance of major human histocompatibility determinants in clinical bone marrow transplantation. Transplantation proceedings. 1976 Information Resource GET IT
Times cited: 8
Heterogeneity of stem cells in severe combined immunodeficiency. Clinical and experimental immunology. 1976 Academic Article GET IT
Times cited: 20
Lymphocyte transformation in vitro to RII mouse milk antigen among woman with breast disease. Cellular immunology. 1976 Academic Article GET IT
Times cited: 5
Effect of human exogenous leukocyte interferon in cytomegalovirus infections. 1976 GET IT
Times cited: 32
Ontogeny of lymphocyte subpopulations in human fetal liver. Proceedings of the National Academy of Sciences of the United States of America. 1976 Academic Article GET IT
Times cited: 66
Circulating polyribophosphate in Hemophilus influenzae, type b meningitis. Correlation with clinical course and antibody response. The Journal of clinical investigation. 1975 Academic Article GET IT
Enhancement of T-lymphocyte differentiation in vitro by thymic extracts after bone marrow transplantation in severe combined immunodeficiencies. Clinical immunology and immunopathology. 1975 Academic Article GET IT
Chronic mucocutaneous candidiasis with macrophage dysfunction, a plasma inhibitor, and co-existent aplastic anemia. The Journal of laboratory and clinical medicine. 1975 Academic Article GET IT
Times cited: 22
Enhancement of T lymphocyte differentiation in vitro by thymic extracts and purified polypeptides in severe combined immunodeficiency diseases. Transactions of the Association of American Physicians. 1975 Academic Article GET IT
Times cited: 5
Paradox of the immune response to uncomplicated gonococcal urethritis. The New England journal of medicine. 1973 Academic Article GET IT
Pseudomonas aeruginosa allergy and humoral antibody-mediated hypersensitivity pneumonia. The American review of respiratory disease. 1973 Academic Article GET IT
Times cited: 10
Chimerism detected by HL-A typing. Transplantation. 1973 Academic Article GET IT
Times cited: 28

more ...

less ...

Background

education and training

M.D., University of Rochester School of Medicine and Dentistry 1968
B.S., College of the Holy Cross 1964

Contact

full name

Richard J. O'Reilly

primary email

oreillyr@mskcc.org

VIVO Weill Cornell Medical College

Richard J. O'Reilly Professor Emeritus of Pediatrics

Publications

selected publications

Background

education and training

Contact

full name

primary email